Back to search

Article

Why Non-HDL Cholesterol is Preferred over Apolipoprotein B-100 (Apo B)

2023-01-18

Abstract excerpt

IMPORTANCE Most studies have found that apo B-100 is a superior marker for Coronary risk (ASCVD) than non-HDL cholesterol (C). Usually, studies use multivariant analysis to compare indexes with single-point odds or risk ratios. In multivariant analysis when variables are highly correlated, they are difficult to interpret and the lesser may be excluded. As a result, effect sizes cannot be well compared. Receiver o...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
87beedb3-42b6-583d-9e61-ef945d067bbf
DOI
10.32388/tulata
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Why Non-HDL Cholesterol is Preferred over Apolipoprotein B-100 (Apo B)DOI 10.32388/tulata
Unmasking residual cardiovascular risk: The paradoxical interaction between remnant cholesterol and calculated LDL-C in a high-risk cohortSemantic proximity
Fasting Blood Glucose to High-Density Lipoprotein Cholesterol Ratio in Relation to Short-Term Outcomes in Patients with Acute Coronary SyndromeSemantic proximity
Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio.Semantic proximity
Discordance analysis of apolipoprotein B and non-high density lipoprotein cholesterol as markers of cardiovascular risk in the INTERHEART study.Semantic proximity
Concordance‐discordance between apolipoprotein B and lipid biomarkers in predicting 20‐year atherosclerotic cardiovascular disease risk: The ATTICA study (2002–2022)Semantic proximity
The C-reactive protein to albumin ratio is a novel prognostic factor in patients with stable coronary artery disease following percutaneous coronary interventionSemantic proximity
Non-HDL cholesterol and apoB in dyslipidaemia.Semantic proximity
Beyond Cholesterol: A Comprehensive Review and Disease Architecture Reassessment of Lipid and Lipoprotein Biomarkers in ASCVDSemantic proximity
Select a neighboring publication to make it the new centre.